{"disease":{"id":"rabies","name":"Rabies","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"abrysvo","indication_name":"Prevention of rabies in individuals who have been bitten or otherwise exposed to rabies or have been at risk of rabies exposure and have been vaccinated with a cell culture vaccine or an inactivated rabies vaccine.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrysvo","generic_name":"abrysvo","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"RSV","drug_class":"vaccine","quality_score":60,"revenue":"1033","mechanism":"ABRYSVO is a vaccine that protects against respiratory syncytial virus (RSV)."},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Rabies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Rabies (pre-exposure)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Rabies (post-exposure)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Rabies (booster)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03667079","title":"Integrating Community Interventions to Eliminate Neglected Tropical Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":28143,"lead_sponsor_name":"Washington State University","has_results":false},{"nct_id":"NCT05667974","title":"A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Yisheng Biopharma (Singapore) Pte. Ltd.","has_results":false},{"nct_id":"NCT07028801","title":"Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Ningbo Rongan Biological Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07500207","title":"A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Changchun BCHT Biotechnology Co.","has_results":false},{"nct_id":"NCT07275645","title":"A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Ab&B Bio-tech Co., Ltd.JS","has_results":false},{"nct_id":"NCT04852068","title":"A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":2480,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT05545371","title":"Prevention of Rabies With Four Doses of Rabies Vaccine","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2100,"lead_sponsor_name":"Changchun Zhuoyi Biological Co., Ltd","has_results":false},{"nct_id":"NCT07357545","title":"Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2040,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT06177249","title":"To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1956,"lead_sponsor_name":"Hualan Biological Bacterin Co. Ltd.","has_results":false},{"nct_id":"NCT06078423","title":"A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1880,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT05549908","title":"Vaccine Prevention of Rabies Adopts 4-shot Immunization Method","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"Changchun Zhuoyi Biological Co., Ltd","has_results":false},{"nct_id":"NCT04127786","title":"Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1708,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05846568","title":"Study to Evaluate GR1801's Efficacy and Safety","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04644484","title":"A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Synermore Biologics (Suzhou) Co., Ltd.","has_results":true},{"nct_id":"NCT07416110","title":"Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":912,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT03965962","title":"Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":640,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT01622062","title":"Immunogenicity and Safety of Verorab® in a \"One-week\" Intradermal Post-exposure Prophylaxis Regimen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT03700242","title":"Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT02545517","title":"A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":459,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03961555","title":"Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Synermore Biologics Co., Ltd.","has_results":true},{"nct_id":"NCT04478084","title":"Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT07055295","title":"Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":390,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07055893","title":"Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":390,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT05453487","title":"Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":360,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT03774628","title":"Immunity Duration of Rabies Vaccine and Booster Dose Effects at 10 Years Post-primary Vaccination","phase":"NA","overall_status":"COMPLETED","enrollment_count":342,"lead_sponsor_name":"Jiangsu Province Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT03145766","title":"Immunogenicity and Safety of a Purified Vero Rabies Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05702008","title":"Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Maulana Azad Medical College","has_results":false},{"nct_id":"NCT07327307","title":"Real World Evidence Study of SYN023 in Children Exposed to Rabies","phase":"","overall_status":"RECRUITING","enrollment_count":232,"lead_sponsor_name":"Synermore Biologics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT05937113","title":"Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Vietnam Military Medical University","has_results":false},{"nct_id":"NCT05684185","title":"Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07012083","title":"Adherence to Anti-rabies Post-exposure Prophylactic Protocols","phase":"","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT04594551","title":"Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT07445815","title":"A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Lanzhou Institute of Biological Products Co., Ltd","has_results":false},{"nct_id":"NCT07120464","title":"Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT04829630","title":"Immunity Persistence After Abridged Intradermal Rabies PEP","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT05350735","title":"Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Washington State University","has_results":false},{"nct_id":"NCT03741270","title":"Safety of Rabivax-S for Pre-exposure Prophylaxis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Ross University School of Veterinary Medicine","has_results":false},{"nct_id":"NCT05832073","title":"Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":152,"lead_sponsor_name":"Changchun BCHT Biotechnology Co.","has_results":false},{"nct_id":"NCT05547815","title":"Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Changchun Zhuoyi Biological Co., Ltd","has_results":false},{"nct_id":"NCT06998004","title":"A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"AstriVax Therapeutics","has_results":false},{"nct_id":"NCT07055880","title":"Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT06548139","title":"Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Changchun BCHT Biotechnology Co.","has_results":false},{"nct_id":"NCT07342257","title":"SYN023 With Rabies Vaccine in Healthy Pediatric Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Synermore Biologics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06433440","title":"Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Peshawar","has_results":false},{"nct_id":"NCT07345208","title":"Safety and Immunogenicity of ID vs IM Rabies Vaccine","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT06132789","title":"A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ab&B Bio-tech Co., Ltd.JS","has_results":false},{"nct_id":"NCT04213950","title":"Improving Adherence to Rabies PEP Guideline Recommendations","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":false},{"nct_id":"NCT07021703","title":"A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ningbo Rongan Biological Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02374814","title":"Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"State University of New York - Upstate Medical University","has_results":true},{"nct_id":"NCT03713086","title":"A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"CureVac","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}